Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00519636 · ClinicalTrials.gov registry record · Phase 4
Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 360
- Enrollment target
NCT00519636: Completed Phase 4 study, sponsored by GlaxoSmithKline.
NCT00519636 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 360 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (31% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00519636, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 360 participants
- Enrollment target
Study Summary
The purpose of this replicate study to FFU105924 is to provide data on subject preference of FFNS as compared with FPNS.
Primary Outcome
Reflective Total Nasal Symptom scores (rTNSS) symptoms of rhinorrhea, nasal congestion, nasal itching, sneezing using scale of: 0=none, 1=mild, 2=moderate, 3=severe; maximum score=12. The mean of AM and PM scores were used.
Interventions
- DRUG FPNS
- DRUG FFNS
- DRUG placebo FPNS
- DRUG placebo FFNS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2007-08 |
| Est. Completion | 2007-11 |
| Phase | Phase 4 |
What the finished NCT00519636 record still lists
NCT00519636 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (31% lower).
The record links to 0 conditions, and to 4 interventions - of which FPNS is the first listed.
NCT00519636 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00519636 about?
NCT00519636 is a clinical study titled "Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS". The purpose of this replicate study to FFU105924 is to provide data on subject preference of FFNS as compared with FPNS.
What is the current status of trial NCT00519636?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 360 participants. The study started on 2007-08. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00519636?
The interventions under investigation include: FPNS (DRUG), FFNS (DRUG), placebo FPNS (DRUG), placebo FFNS (DRUG).
Who is sponsoring clinical trial NCT00519636?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00519636's enrollment target sits among peer trials
360 225th of 2000 higher than 1,775 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia